Market Overview The genomics cancer market is experiencing immunogenomics emphasis where immune gene expression and checkpoint analysis guide immunotherapy selection and predict response. The genomics cancer market is projected to exceed USD 24.8 billion through 2030, with immunogenomics emphasis driven by checkpoint therapy dominance, response prediction importance, and precision...